Ruby Bio

Oakland, CA · Founded 2022 · Privately Held (backing)

Developer of a biomanufacturing platform intended for producing bio-based chemicals and ingredients from renewable feedstocks. Ruby Bio is based in Oakland, CA and was founded in 2022. It was valued at $24 million at its seed round in Jun 2025, the last priced event on record. It has raised $8 million across 2 recorded rounds; the latest was an $8 million early-stage round in May 2025.

PMV mark · valuation
$24.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$8.0M
Last round
Early Stage VC
May 2025
How much has Ruby Bio raised?
$8.0Macross 2 recorded rounds · Sep 2022 – May 2025

Most recently, Ruby Bio raised $8.0M in its Early Stage VC (May 2025).

Free account
More of Ruby Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Ruby Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ruby Bio round by round

2 rounds
May 2025Early Stage VC$8.0MSEC filing▮
22 investors participated
Sep 2022Early Stage VC$5.1MSEC filing▮
14 investors participated

How much has Ruby Bio raised?

Ruby Bio has raised $8 million across 2 recorded rounds since 2022. The largest was an $8 million early-stage round in May 2025.

Ruby Bio has filed 3 Form Ds with the SEC since 2022, most recently in Jun 2025 ($8 million sold to 22 investors).

Ruby Bio investors

12 investors are on record for Ruby Bio, including Alumni Ventures, gener8tor, Joyance Partners and Dhuna Ventures. By type, the record holds 5 venture capital firms. The early-stage round in May 2025 drew 22 investors.

For fundraisers
Raising for a company like Ruby Bio?

12 investors have backed Ruby Bio.

See all 12 investors →

Frequently asked about Ruby Bio

How much has Ruby Bio raised?
Ruby Bio has raised $8.0M in total across 2 recorded funding rounds.
When was Ruby Bio's last funding round?
Ruby Bio's most recent recorded round was Early Stage VC in May 2025, raising $8.0M.